Can natural killer cells cure leukemia?
Frank Cichocki, Martin Felices, Anders W Matson, Madeline J Lee, Jeffrey S Miller · 2026
Read Can natural killer cells cure leukemia? by Frank Cichocki, Martin Felices, Anders W Matson, Madeline J Lee, Jeffrey S Miller (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13421307.txt.
Description
Frank Cichocki and four colleagues ask directly, in the title of their 2026 review, whether natural killer cells can cure leukaemia. Natural killer cells are immune cells that attack tumours without the graft-versus-host disease and severe inflammatory reactions that make T-cell therapy risky.
By 2025, around 140 companies were developing some 160 natural-killer strategies. Their ideas ranged from donor cell products to molecules that unleash the patient's own cells. Thousands of patients have been treated in trials over two decades. The review weighs strong anti-tumour activity and off-the-shelf manufacturing against stubborn limits, notably poor persistence and weak antigen targeting. The authors' verdict is measured: the safety case is proven, while the durability needed for cures is not yet.
Catalog record
| CREATOR | Frank Cichocki, Martin Felices, Anders W Matson, Madeline J Lee, Jeffrey S Miller |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13046 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |